Clinical News News, Page 1 – Pharmaceutical Technology #cerulean #pharma

Posted On Dec 21 2016 by

#pharmaceutical companies news # Clinical News – Page 1 Stay up to date with the latest Clinical News updates from the global pharmaceutical industry Latest Clinical News Update Pfizer, DCRI and partners collaborate to improve adult vaccination rates 02 September, 2016 Pfizer, Duke Clinical Research Institute (DCRI), Duke Primary Care, and Premier have collaborated to work together to improve adult vaccination rates within a primary care. read more Sunovion to acquire Canada’s Cynapsus Therapeutics for $624m Friday, September 02, 2016 Sunovion Pharmaceuticals has signed an agreement to acquire Canadian-based Cynapsus Therapeutics for. New report says age and general wellbeing can …


The top 10 most expensive drugs of 2013 #pharmaceutical #companies #in #canada

Posted On Dec 21 2016 by

#pharmaceutical companies news # The top 10 most expensive drugs of 2013 The price of Gilead Sciences’ breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, Gilead Sciences ($GILD) has been pilloried by politicians, payers and providers. But as EvaluatePharma points out, at that price Sovaldi barely makes it into the top 20 most expensive drugs. number 19 to be exact, just above Novartis’ ($NVS) Gleevec and just below GlaxoSmithKline’s ($GSK) Mekinist. Sovaldi is pricey, but if you want to talk about really pricey, then look at the 10 …


Massachusetts Contract Research & Contract Manufacturing – Massachusetts Biotechnology Council #pharma #cro

Posted On Dec 21 2016 by

#pharmaceutical companies in boston # Contract Research & Contract Manufacturing in MA Massachusetts has become a center of excellence for innovation in drug development, due in no small part to the strength of its contract research and manufacturing capabilities the CRO/CMO Cluster. To provide direct, real-time access to the CRO/CMO community and streamline access to its unique resources, MassBio launched the MA CRO/CMO Gateway in partnership with OnDeckBiotech. The Gateway is connected with the Bio BizLink which allows users outside the Commonwealth to connect to the Massachusetts community of CROs and CMOs. For biotech and drug development companies, the Gateway …


Hanford Pharmaceuticals #pharmaceutical #companies #usa

Posted On Dec 21 2016 by

#pharmaceutical companies in new york # A Veterinary Leader With a rich heritage dating back to the mid-1800’s, Hanford Pharmaceuticals has been a world leader in providing quality veterinary products to American food producers. Hanford Pharmaceuticals is committed to America’s food producers by offering quality veterinary products that maintain the health and quality of life of herds. Throughout the United States veterinarians and producers rely on Hanford’s outstanding products to improve the productivity of their livestock. Hanford’s mission is providing and maintaining superior quality veterinary products to our customers and to ensure their satisfaction. Our future has never been more …


Pharma – s top 10 M – A deals of 2014 – s first half #dr #reddy #pharma

Posted On Dec 21 2016 by

#pharmaceutical companies news # Pharma s top 10 M A deals of 2014 s first half Mergers and acquisitions have been non-stop this year, with lots of deals done, and some doozies that were unable to cross the finish line. Here we look at what’s happened in the first half of the year; we will round out the entire year’s activity in another report early next year. The top 10 deals in the first half of 2014 totaled nearly $90 billion in value, with Actavis’ ($ACT) $25 billion deal for Forest topping the list. According to EvaluatePharma’s estimates. the deals …


EMEA finalises EU pharma guideline procedure #ista #pharma

Posted On Dec 21 2016 by

#pharma guidelines # EMEA finalises EU pharma guideline procedure By 01-Jul-2005 2005-07-01T00:00:00Z The European Medicines Agency (EMEA) has finalised a new procedure designed to make the process for the development, consultation, finalisation and implementation of pharmaceutical guidelines clearer. The response by Europe’s main pharmaceutical regulatory body, aims to tighten up and clarify new guidelines, keeping in line with the European Union’s harmonisation activities with Japan, US and other international partners through the international conferences on harmonisation for human and veterinary medicines (ICH and VICH). The procedure was drawn up in an attempt to give guidance to applicants and/or sponsors planning …


Legal and Regulatory News, Page 1 – Pharmaceutical Technology #dragon #pharma

Posted On Dec 21 2016 by

#pharmaceutical companies news # Legal and Regulatory – Page 1 Stay up to date with the latest Legal and Regulatory updates from the global pharmaceutical industry Latest Legal and Regulatory Update US FDA approves Genmab’s ofatumumab for relapsed CLL 01 September, 2016 Danish biotechnology company Genmab has received the US Food and Drug Administration (FDA) approval for ofatumumab (Arzerra) in combination with fludarabine and cyclophosphamide (FC) to. read more RedHill Biopharma’s RHB-104 receives EU patent for multiple sclerosis treatment Wednesday, August 31, 2016 The European Patent Office (EPO) has issued a European patent covering the use of RedHill Biopharma’s RHB-104 …


Our Services to the Pharmaceuticals and Life Sciences Industry, PwC Canada #pharmaceutical #conference

Posted On Dec 21 2016 by

#pharmaceutical companies in canada # Pharmaceuticals and Life Sciences Helping the business of health by improving the health of business Is it any surprise that Canada’s life sciences and pharmaceutical industry receives one out of every four dollars of venture capital investment? After all, an aging Canadian population has significantly increased demand for health-related products and treatment, and the sector is working hard to keep up. With the global pharmaceutical market predicted to double to $1.8 trillion by 2020, there is a lot at stake for Canadian players in this sector. Yet there are unique challenges facing our life sciences …


Home – WELLSPRING PHARMACEUTICALWELLSPRING PHARMACEUTICAL #big #pharma

Posted On Dec 21 2016 by

#pharmaceutical companies in canada # About Us Founded in 1999, WellSpring Pharmaceutical Corporation is a privately held company focused on the development, manufacturing and marketing of over-the-counter products for the U.S. and Canadian markets. In addition, the company offers pharmaceutical contract manufacturing services to other companies across North America and Europe. WellSpring owns and operates an FDA and Health Canada registered and inspected manufacturing plant in Oakville, Ontario, Canada. The company’s headquarters are located in Sarasota, Florida. Our Investors In October 2011 WellSpring was acquired by Sentinel Capital Partners and Ancor Capital Partners in partnership with its management team. Our …


Pharmaceutical Company List #ariad #pharma

Posted On Dec 21 2016 by

#pharmaceutical companies in canada # Pharmaceutical Company List Pharmaceutical, biopharmaceutical and allied industries encompass companies operating in every province across Canada. It currently employs highly skilled and highly paid work force including doctors, chemists, scientists, biologists, microbiologists, engineers, and other professionals. Within the pharmaceutical industry, the brand-name sector employs approximately 20,000 people, bio-pharmaceutical firms employ about 7,000, and over 4,500 are employed by the generic drug manufacturers. In addition, pharmaceutical related activities provide opportunity for another 100,000 people nationally. REQUEST INFORMATION TESTIMONIAL I just want to say thank you for your support in behalf of all the students in your …